Dr Alia Aslam, Dr Tasneem Shoukat, Dur-e-Zarnab Zahra
In spite of the accessibility of profoundly compelling treatment for hepatitis C infection (HCV) contamination, hardly any patients get treatment. Barriers to the transport of hepatitis C treatment may be blocked at various stages from the discovery to the provision. At patient level, lack of care, fear of consequences, commitment to the treatment and co-morbid conditions can prevent therapy. For suppliers, restricted information, absence of accessibility and correspondence challenges may be dangerous. At the legislature and payer level, an absence of advancement, reconnaissance what's more, financing may meddle. In any case, for compelling treatment to be conveyed, long-standing hindrances to treatment should be tended to. Moreover, with expanded costs, higher paces of unfavorable occasions, and convoluted treatment calculations, more up to date specialists may introduce significantly more noteworthy difficulties to patients and doctors. Our current research was conducted at Jinnah Hospital, Lahore from May 2019 to April 2020. A comprehension of existing boundaries to HCV treatment is essential to help manage activities pointed toward improving treatment rates what's more, eventually, results. Every one of these boundaries should be tended to if more extensive usage of antiviral treatment is to be accomplished. Keywords: Restricted Information, Loss, Connectivity, Hepatitis.